tirzepatide phase 3 study results SURMOUNT-3: shows total mean weight loss of 26.6% from entry over 84 weeks Tirzepatide for the Treatment of

This once-weekly injection is changing the way patients approach weight management, offering real results without extreme diets or surgical procedures

10 BaumannG.AmburnK.ShawM

Products like berberine, oats, and apple cider vinegar are among those with the strongest online presence

Impact of loop diuretic on outcomes in patients with heart failure and reduced ejection fraction

There are currently no randomised controlled trials evaluating GLP-1 receptor agonists as a treatment for rheumatoid arthritis, and these medications are not licensed or recommended for this indication by the MHRA, NICE, or the European Medicines Agency (EMA)